You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

5 Alpha-Reductase Inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Benign Prostatic Hyperplasia (BPH) Trial in France (REZUM, alpha blocker and 5-alpha reductase inhibitor)

Recruiting
  • Benign Prostatic Hyperplasia (BPH)
  • REZŪM
  • alpha blocker and 5-alpha reductase inhibitor
  • Aix-en-Provence, France
  • +9 more
Jul 26, 2022

Benign Prostatic Hyperplasia Trial in Seoul (combination therapy, alpha blocker monotherapy, 5 alpha reductase inhibitor

Completed
  • Benign Prostatic Hyperplasia
  • combination therapy
  • +2 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 28, 2019

Benign Prostatic Hyperplasia, Prostate Hyperplasia, Prostate Disease Trial in Boston (Finasteride)

Recruiting
  • Benign Prostatic Hyperplasia
  • +7 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 26, 2022

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023

Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency Trial in Worldwide (Alpha-1 MP)

Enrolling by invitation
  • Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
  • Alpha-1 MP
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Pulmonary Emphysema in Alpha-1 PI Deficiency Trial in Worldwide (Alpha-1 MP, 0.9% Sodium Chloride for Injection, USP)

Recruiting
  • Pulmonary Emphysema in Alpha-1 PI Deficiency
  • Alpha-1 MP
  • 0.9% Sodium Chloride for Injection, USP
  • Phoenix, Arizona
  • +50 more
Dec 7, 2022

Myocardial Infarction, Statin Adverse Reaction, HMG-CoA Reductase Inhibitor Toxicity Trial in Korea, Republic of (Rosuzet 10/5

Recruiting
  • Myocardial Infarction
  • +2 more
  • Ezetimibe 10mg + Rosuvastatin 5mg
  • Rosuvastatin 20mg
  • Bucheon, Gyeonggido, Korea, Republic of
  • +6 more
Sep 2, 2022

COPD, Alpha1-antitrypsin Deficiency Trial in Australia, Canada, United States (ARALAST NP 60 mg/kg, ARALAST NP 120 mg/kg,

Terminated
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Alpha1-antitrypsin Deficiency
  • ARALAST NP 60 mg/kg
  • +4 more
  • Peoria, Arizona
  • +16 more
Apr 17, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • (no location specified)
Jan 14, 2023

Prostatic Tumors, Low Grade Prostate Cancer Trial in Quebec (Dietary intervention first, Drug (Dutasteride) intervention first)

Active, not recruiting
  • Prostatic Neoplasms
  • Low Grade Prostate Cancer
  • Dietary intervention first
  • Drug (Dutasteride) intervention first
  • Quebec, Canada
  • +1 more
Mar 14, 2022

Prostatic Hyperplasia, Prostate Hyperplasia, Prostatic Hypertrophy Trial in Seoul (alpha-blocker or 5-ARI withdrawal,

Recruiting
  • Prostatic Hyperplasia
  • +2 more
  • alpha-blocker or 5-ARI withdrawal
  • Maintenance of alpha-blocker and 5-ARI
  • Seoul, Korea, Republic of
    Gangnam Severance Hospital, Yonsei University College of Medicin
Aug 21, 2021

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Alpha1-antitrypsin Deficiency, Healthy Volunteers Trial in Overland Park (Alpha1-proteinase inhibitor, Placebo: Human albumin

Completed
Has Results
  • Alpha1-antitrypsin Deficiency
  • Healthy Volunteers
  • Alpha1-proteinase inhibitor
  • Placebo: Human albumin 2.5%
  • Overland Park, Kansas
    (unnamed)
May 3, 2021

Alpha1-antitrypsin Deficiency Trial in Canada, United States (GLASSIA)

Completed
Has Results
  • Alpha1-antitrypsin Deficiency
  • GLASSIA
  • Tucson, Arizona
  • +17 more
Sep 17, 2021

Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System Trial in Tampa, Gainesville (Testosterone Enanthate,

Terminated
  • Spinal Cord Injury
  • +10 more
  • Testosterone Enanthate
  • +3 more
  • Tampa, Florida
  • +1 more
Jul 28, 2022

Alzheimer Trial in Worldwide (neflamapimod, )

Completed
Has Results
  • Alzheimer Disease
  • Long Beach, California
  • +37 more
Sep 28, 2021

C677T Methylenetetrahydrofolate Reductase Mutation

Completed
  • Mutation
  • infertily evaluation
  • (no location specified)
May 16, 2023

Carcinoma, Non-small Cell Lung Trial in Changsha (ethaselen)

Completed
  • Carcinoma, Non-small Cell Lung
  • Changsha, Hunan, China
    Hunan province tumor hospital
Mar 1, 2022

Other Specified Hypotension, Syncope Trial in Vancouver (Acarbose, Placebo)

Completed
  • Other Specified Hypotension
  • Syncope
  • Vancouver, British Columbia, Canada
    Vancouver Coastal Health Research Institute, VGH Research Pavili
May 26, 2021

Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick

Active, not recruiting
  • Ann Arbor Stage III Non-Hodgkin Lymphoma
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 28, 2023

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in

Not yet recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +6 more
  • Biopsy
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 26, 2022

Baby Detect : Genomic Newborn Screening

Recruiting
  • Congenital Adrenal Hyperplasia
  • +126 more
    • Liege, Wallonia, Belgium
      CRMN, Hôpital La Citadelle
    Jan 24, 2023